News
Selank and Cognitive Protection During GLP-1 Th...
Preprint data suggest 30-40% of semaglutide users report brain fog. Selank, a tuftsin analogue, is being explored for cognitive protection during GLP-1
Selank and Cognitive Protection During GLP-1 Th...
Preprint data suggest 30-40% of semaglutide users report brain fog. Selank, a tuftsin analogue, is being explored for cognitive protection during GLP-1